Effect of pharmaceutical excipients on the stability of trichlormethiazide tablets under humid conditions. 2009

Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Motoyama-kitamachi, Higashi-nada, Japan. teraoka@kobepharma-u.ac.jp

The stability of trichlormethiazide (TCM) and the drug in the nine products available on the market (the original tablet (B) and 8 generic tablets (G1-G8)) were investigated under humid conditions. TCM was non-hygroscopic and was not degraded under humid conditions. Drug degradation in aqueous ethanol was accelerated with increased water concentration, and the drug stability in buffer solution was improved with decreased pH. TCM decomposition was not detected in each unwrapped tablet at low relative humidity. However, rapid degradation was observed for products G1 and G2, while product B and G7 showed higher stability at high relative humidity. The stability of products G1 and G2 decreased with increasing humidity. The same results were observed for the tablets in press-through packages (PTP), but the degradation rate was much slower than tablets without PTP packages. These results suggested that the adsorbed moisture by excipients cause TCM degradation. Various pharmaceutical excipients are added to TCM tablets and these vary between different pharmaceutical companies. Intact drug and pharmaceutical excipients, including lactose, microcrystalline cellulose, corn starch, hydroxypropylcellulose (HPC), low substituted HPC (L-HPC), calcium stearate, and light anhydrous silicic acid, were mixed, and the sample mixtures were stored in humid conditions. It was found that the TCM content decreased significantly in a binary mixture of TCM/HPC 1 : 1.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D006813 Humidity A measure of the amount of WATER VAPOR in the air. Humidities
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D014237 Trichlormethiazide A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p830) Aquazide,Naqua,Triazide,Trichloromethiazide
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
January 2008, Chemical & pharmaceutical bulletin,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
October 1990, Journal of clinical pharmacy and therapeutics,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
October 2003, International journal of pharmaceutics,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
April 2007, Chemical & pharmaceutical bulletin,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
February 2008, International journal of pharmaceutics,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
January 2021, Pharmaceutical development and technology,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
March 2021, Pharmaceutics,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
January 2016, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
January 2005, Acta poloniae pharmaceutica,
Reiko Teraoka, and Yuki Matsushima, and Isao Sugimoto, and Kana Inoue, and Shin-ya Morita, and Shuji Kitagawa
September 1999, Bollettino chimico farmaceutico,
Copied contents to your clipboard!